Researcher
Rik Gijsbers
- Disciplines:Molecular medicine
Affiliations
- Molecular Virology and Gene Therapy (Division)
Member
From1 Oct 2005 → Today - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Aug 2003 → 30 Sep 2005
Projects
1 - 10 of 35
- Gene editing for cystic fibrosis - tackling the translatability hurdleFrom10 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organoid technologies for disease modeling, drug discovery and development for rare diseasesFrom1 Jan 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Using iPS cells to regenerate muscleFrom26 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The GEne Therapy INnovation Training NetworkFrom1 Sep 2023 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Downstream bioseparation with membrane technologyFrom25 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The GEne Therapy INnovation Training NetworkFrom1 Apr 2023 → TodayFunding: BOF - projects
- Gene therapeutic intervention during ex vivo lung perfusion as a platform to modulate human lung diseaseFrom1 Oct 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Building a proprietary platform for DNA-antibody based therapeuticsFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Next Steps in HBV Vaccine Research: Novel Small Animal Models for HBV Infection and Innovative Microneedle Patch-Based Vaccine Delivery MethodsFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Predicting metastasis formation based on cancer cells with a distinct energy metabolismFrom1 Oct 2022 → TodayFunding: BOF - projects
Publications
11 - 20 of 166
- A Novel Homozygous Stop Mutation in IL23R Causes Mendelian Susceptibility to Mycobacterial Disease(2022)
Authors: Frederik Staels, Margaux Gerbaux, Julika Neumann, Thomas Tousseyn, Emanuela Pasciuto, Paul De Munter, Xavier Bossuyt, Rik Gijsbers, Adrian Liston, Stephanie Humblet-Baron, et al.
Pages: 1638 - 1652 - Evaluation of the molecular mechanisms of STAT1 Gain-Of-Function using engineered cell models(2022)
Authors: Simone Giovannozzi, Rik Schrijvers, Rik Gijsbers
- Urine-Derived Kidney Progenitor Cells in Cystinosis(2022)
Authors: Sante Princiero Berlingerio, Dries David, Tjessa Bondue, Koen Theunis, Joris Vriens, Rik Gijsbers, Elena Levtchenko
- Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation(2022)
Authors: Rik Gijsbers
Pages: 550 - 569 - Improved functionality and potency of next generation BinMLV viral vectors towards safer gene therapy(2021)
Authors: Maurilio Sampaolesi, Rik Gijsbers
Pages: 51 - 67 - Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning(2021)
Authors: Rik Gijsbers
Pages: 3383 - 3397 - Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning(2021)
Authors: Rik Gijsbers
Pages: 3383 - 3397 - CRISPR/Cas9-Induced Mutagenesis Corroborates the Role of Transportin-SR2 in HIV-1 Nuclear Import(2021)
Authors: Julie Janssens, Rik Gijsbers, Frauke Christ, Zeger Debyser
- Development of isogenic myoblast-based models to study cystinosis myopathy(2021)
Authors: Louise Medaer, Dries David, Maurilio Sampaolesi, Rik Gijsbers
Pages: A81 - A81 - Base and prime editing as potential gene correction therapy for cystic fibrosis(2021)
Authors: Mattijs Bulcaen, Marjolein Ensinck, François Vermeulen, Rik Gijsbers, Zeger Debyser, Marianne Carlon
Pages: A71 - A71
Patents
1 - 4 of 4